Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > AstraZeneca COVID Vaccine Put On Hold - "Adverse Reaction"

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Sep 08, 2020 6:06pm

128 Views

Post# 31524314

RE:AstraZeneca COVID Vaccine Put On Hold - "Adverse Reaction"

Just goes to show none of these phase 3 vaccines are home runs ......this tortoise my win the race !!!

peck6891 wrote: https://www.zerohedge.com/medical/astrazeneca-shares-plunge-covid-vaccine-study-put-hold-due-adverse-reaction

AstraZeneca Shares Plunge As COVID Vaccine Study Put On Hold Due To "Adverse Reaction"

by Tyler Durden

Tue, 09/08/2020 - 17:29

Amid the biggest selloff in markets since March, we suspect news from AstraZeneca's massive Phase 3 COVID-19 study will not help at all.

Stat News reports that the large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.

An individual familiar with the development said researchers had been told the hold was placed on the trial out of “an abundance of caution.”

AstraZeneca ADRs are down over 8% after hours...

Perhaps of even greater import, Stat News reports that a second individual familiar with the matter, who also spoke on condition of anonymity, said the finding is having an impact on other AstraZeneca vaccine trials underway — as well as on the clinical trials being conducted by other vaccine manufacturers.

There are currently nine vaccine candidates in Phase 3 trials. AstraZeneca’s is the first Phase 3 Covid-19 vaccine trial known to have been put on hold.